Return to QS33 Overview

Rheumatoid arthritis in over 16s [QS33]

Measuring the use of this guidance

Statement: 1

People with suspected persistent synovitis affecting the small joints of the hands or feet, or more than 1 joint, are referred to a rheumatology service within 3 working days of presentation.

Quality standard measure: Proportion of people with suspected persistent synovitis affecting the small joints of the hands or feet, or more than 1 joint, who are referred to a rheumatology service within 3 working days of presentation.
What was measured: Proportion of people with early inflammatory arthritis referred to a rheumatology service within three days of presentation to primary care.
Data collection end: April 2015
17%
Data collection end: January 2016
20%
Number that met the criteria: 1020
Area covered: England and Wales
Source: The British Society for Rheumatology. National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.


Statement: 2

People with suspected persistent synovitis are assessed in a rheumatology service within 3 weeks of referral.

Quality standard measure: Proportion of people with suspected persistent synovitis who are assessed in a rheumatology service within 3 weeks of referral.
What was measured: Proportion of people with early inflammatory arthritis who were seen within 3 weeks of receipt of referral to rheumatology service
Data collection end: April 2015
38%
Data collection end: January 2016
37%
Number that met the criteria: 1844
Area covered: England and Wales
Source: The British Society for Rheumatology. National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.


Statement: 4

People with rheumatoid arthritis are offered educational and self-management activities within 1 month of diagnosis.

Quality standard measure: Proportion of people with rheumatoid arthritis who are offered educational and self-management activities within 1 month of diagnosis.
What was measured: Proportion of people with rheumatoid arthritis who were offered educational and self-management activities within 1 month of diagnosis when they returned for follow up.
Data collection end: April 2015
59%
Data collection end: January 2016
67%
Number that met the criteria: 1438
Area covered: England and Wales
Source: The British Society for Rheumatology. National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.


Statement: 6

People with rheumatoid arthritis and disease flares or possible drug-related side effects receive advice within 1 working day of contacting the rheumatology service.

Quality standard measure: Evidence of local arrangements for people with rheumatoid arthritis and disease flares or possible drug-related side effects receive advice within 1 working day of contacting the rheumatology service.
What was measured: Proportion of Trusts that reported access to a telephone advice service for people with inflammatory arthritis who had a flare of arthritis.
Data collection end: April 2015
96%
Data collection end: January 2016
92%
Number that met the criteria: 4597
Area covered: England and Wales
Source: The British Society for Rheumatology. National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.


Statement: 7

People with rheumatoid arthritis have a comprehensive annual review that is coordinated by the rheumatology service.

Quality standard measure: Evidence of local arrangements for people with rheumatoid arthritis to have a comprehensive annual review that is coordinated by the rheumatology service.
What was measured: Proportion of Trusts that reported that they had a formal or informal annual review process in place for people with rheumatoid arthritis.
Data collection end: April 2015
100%
Data collection end: January 2016
82%
Area covered: England and Wales
Source: The British Society for Rheumatology. National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.

Quality standard measure: Proportion of people with rheumatoid arthritis diagnosed more than 1 year ago whose last comprehensive review was within 12 months of diagnosis or the previous review.
What was measured: Proportion of patients with rheumatoid arthritis, on the register, who have had a face-to-face review in the preceding 12 months.
Data collection end: March 2015
84.3%
Area covered: England
Source: Health and Social Care Information Centre. Quality Outcomes Framework.

Quality standard measure: Proportion of people with rheumatoid arthritis diagnosed more than 1 year ago whose last comprehensive review was within 12 months of diagnosis or the previous review.
What was measured: RA002: The percentage of patients with rheumatoid arthritis, on the register, who have had a face-to-face review in the preceding 12 months.
Data collection end: March 2016
84.3%
Data collection end: March 2017
85.4%
Area covered: National
Source: Health and Social Care Information Centre. Quality and Outcomes Framework.


Archived quality statements

Quality statements that are no longer current have been archived.

View archived quality statements

 Return to QS33 Overview